An investigation on behalf of investors of Innoviva Inc shares was announced concerning possible violations of securities laws by Innoviva Inc and certain of its directors and officers.
Investors who purchased shares of Innoviva Inc (NASDAQ:INVA), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Innoviva Inc (NASDAQ:INVA) concerning whether certain statements by Innoviva Inc (NASDAQ:INVA regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva Inc reported that its annual Total Revenue rose from $8.43 million in 2014 to $133.57 million in 2016 and that its Net Loss of $168.46 million in 2014 turned into a Net Income of $59.54 million in 2016.
Those who purchased NASDAQ:INVA shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego